1.1 	A bill for an act
1.2 	relating to health; establishing the Long-Term Resident Access to 
1.3 	Pharmaceuticals Act;amending Minnesota Statutes 2006, section 151.19, 
1.4 	subdivision 2; proposing coding for new law in Minnesota Statutes, chapter 151.
1.5 	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

1.6 	Section 1. Minnesota Statutes 2006, section 151.19, subdivision 2, is amended to read:
1.7 		Subd. 2.Nonresident pharmacies. The board shall require and provide for an 
1.8 	annual nonresident special pharmacy registration for all pharmacies located outside of this 
1.9 	state that regularly dispense medications for Minnesota residents and mail, ship, or deliver 
1.10 	prescription medications into this state. Nonresident special pharmacy registration shall 
1.11 	be granted by the board upon the disclosure and certification by a pharmacy:
1.12 	(1) that it is licensed in the state in which the dispensing facility is located and from 
1.13 	which the drugs are dispensed;
1.14 	(2) the location, names, and titles of all principal corporate officers and all 
1.15 	pharmacists who are dispensing drugs to residents of this state;
1.16 	(3) that it complies with all lawful directions and requests for information from 
1.17 	the Board of Pharmacy of all states in which it is licensed or registered, except that it 
1.18 	shall respond directly to all communications from the board concerning emergency 
1.19 	circumstances arising from the dispensing of drugs to residents of this state;
1.20 	(4) that it maintains its records of drugs dispensed to residents of this state so that the 
1.21 	records are readily retrievable from the records of other drugs dispensed;
1.22 	(5) that it cooperates with the board in providing information to the Board of 
1.23 	Pharmacy of the state in which it is licensed concerning matters related to the dispensing 
1.24 	of drugs to residents of this state; and
2.1 	(6) that during its regular hours of operation, but not less than six days per week, for 
2.2 	a minimum of 40 hours per week, a toll-free telephone service is provided to facilitate 
2.3 	communication between patients in this state and a pharmacist at the pharmacy who has 
2.4 	access to the patients' records; the toll-free number must be disclosed on the label affixed 
2.5 	to each container of drugs dispensed to residents of this state.; and
2.6 	(7) that, upon request of a resident of a long-term care facility located within the 
2.7 	state of Minnesota, the resident's authorized representative, or a contract pharmacy or 
2.8 	licensed health care facility acting on behalf of the resident, the pharmacy will dispense 
2.9 	medications prescribed for the resident in unit-dose packaging or, alternatively, comply 
2.10 	with the provisions of section 151.415, subdivision 5.

2.11 	Sec. 2. [151.415] LONG-TERM CARE RESIDENT ACCESS TO 
2.12 	PHARMACEUTICALS ACT.
2.13 		Subdivision 1.Title; citation. This section may be cited as the "Long-Term Care 
2.14 	Resident Access to Pharmaceuticals Act."
2.15 		Subd. 2.Definitions. For the purposes of this section, the following terms have the 
2.16 	meanings given them unless otherwise provided by text:
2.17 	(a) "Board" means the Board of Pharmacy.
2.18 	(b) "Contract pharmacy" means a pharmacy, licensed under this chapter, which is 
2.19 	under contract to a long-term care facility.
2.20 	(c) "Long-term care facility" means a nursing home licensed under sections 144A.02 
2.21 	to 144A.10, or a boarding care home licensed under sections 144.50 to 144.56. Facilities 
2.22 	not certified under title XIX of the federal Social Security Act are not included in this 
2.23 	definition. 
2.24 	(d) "Original dispensing pharmacy" shall mean a pharmacy, licensed in any state in 
2.25 	the United States, which dispenses drugs in bulk prescription containers to a person who 
2.26 	is a resident in a long-term care facility.
2.27 		Subd. 3.Authorization to administer and repackage drugs. (a) A contract 
2.28 	pharmacist or pharmacy may repackage a resident's prescription drugs, which have been 
2.29 	lawfully dispensed from bulk prescription containers by an original dispensing pharmacy, 
2.30 	into a unit-dose system compatible with the system used by the long-term care facility.
2.31 	(b) A long-term care facility may administer drugs to residents of the facility that 
2.32 	have been repackaged according to this subdivision. The contract pharmacy shall notify 
2.33 	the long-term care facility whenever medications have been dispensed according to 
2.34 	this subdivision and must certify that the repackaging and dispensing has been done in 
2.35 	accordance with this subdivision.
3.1 	(c) Drugs may be dispensed for a resident of a long-term care facility according to 
3.2 	this subdivision, provided that:
3.3 	(1) the drug is dispensed by the original dispensing pharmacy according to a current, 
3.4 	valid prescription;
3.5 	(2) the original bulk prescription container for the resident is delivered by the 
3.6 	original dispensing pharmacy directly to the contract pharmacist or pharmacy;
3.7 	(3) the contract pharmacist or pharmacy verifies the name and strength of the drug, 
3.8 	the name of the manufacturer of the drug, the manufacturer's lot or control number, the 
3.9 	manufacturer's expiration date for the drug, and the date the drug was dispensed by the 
3.10 	original dispensing pharmacy;
3.11 	(4) the contract pharmacist or pharmacy verifies the validity and accuracy of the 
3.12 	current prescription order;
3.13 	(5) the contract pharmacist or pharmacy repackages the drug in board-approved 
3.14 	unit-dose packaging, with labeling that complies with Minnesota Rules, part 6800.6300, 
3.15 	and that identifies that the drug has been repackaged according to this section;
3.16 	(6) the resident for whom the medication is repackaged obtains medications from or 
3.17 	receives medications at a discounted rate from the original dispensing pharmacy under the 
3.18 	resident's state or federal health assistance program or a private health insurance plan; and
3.19 	(7) the resident for whom the medication is to be repackaged, or the resident's 
3.20 	authorized representative, has signed an informed consent form provided by the facility 
3.21 	which includes an explanation of the repackaging process and which notifies the resident 
3.22 	of the immunities from liability provided in this section.
3.23 		Subd. 4.Maintenance of records. For each drug repackaged by a contract 
3.24 	pharmacy under this section, the contract pharmacy shall maintain a record for at least 
3.25 	two years of the following information:
3.26 	(1) the name, manufacturer, manufacturer's lot number, manufacturer's expiration 
3.27 	date, and quantity of the drug prescribed;
3.28 	(2) the name and address of the resident for whom the drug was repackaged;
3.29 	(3) the name and address or other identifier of the prescriber;
3.30 	(4) the date the prescription was issued and the date the drug was repackaged;
3.31 	(5) the date the repackaged drug was delivered to the long-term care facility;
3.32 	(6) the directions for use;
3.33 	(7) a copy of the label that was affixed to the repackaged drug;
3.34 	(8) the initials of the packager;
3.35 	(9) the initials of the supervising pharmacist; and
3.36 	(10) the name and business address of the original dispensing pharmacy.
4.1 		Subd. 5.Duties of the original dispensing pharmacy. Upon request of the 
4.2 	resident, the resident's authorized representative, or a contract pharmacy or licensed 
4.3 	health care facility acting on behalf of the resident, the original dispensing pharmacy 
4.4 	is required to deliver medications dispensed for the resident directly to the contract 
4.5 	pharmacist or pharmacy. The original dispensing pharmacy is further required to provide 
4.6 	the contract pharmacist or pharmacy with the name and strength of the drug, the name of 
4.7 	the manufacturer of the drug, the manufacturer's lot or control number, the manufacturer's 
4.8 	expiration date for the drug, and the date the drug was dispensed.
4.9 		Subd. 6.Redispensing of returned drugs prohibited. Unused drugs repackaged 
4.10 	according to this section that are returned to any pharmacy shall not be redispensed.
4.11 		Subd. 7.Immunity from civil liability. (a) A contract pharmacist or pharmacy 
4.12 	and its employees or agents repackaging a drug acquired from an original dispensing 
4.13 	pharmacy shall be immune from civil liability arising from harm caused by the drug due 
4.14 	to acts or omissions of other persons outside of the contract pharmacist or pharmacy if the 
4.15 	contract pharmacist or pharmacy properly repackages the drug according to this section.
4.16 	(b) A long-term care facility and the facility's employees or agents who properly 
4.17 	administer a drug repackaged by a contract pharmacist or pharmacy under this section 
4.18 	shall be immune from civil liability arising from harm caused by the drug due to acts or 
4.19 	omissions of other persons outside the long-term care facility.
4.20 		Subd. 8.Handling fee. A contract pharmacist or pharmacy may charge a monthly 
4.21 	fee of no more than 250 percent of the medical assistance program dispensing fee for 
4.22 	each drug repackaged according to this section, but no more than $100 per month for 
4.23 	each individual resident.